New players in the treatment of hypercholesterolaemia: focus on bempedoic acid and inclisiran

Dyslipidaemias and in particular elevated plasma low-density lipoprotein cholesterol (LDL-C) levels are major risk factors for atherosclerotic cardiovascular disease (ASCVD). Indeed, the more LDL-C is reduced the larger will be the ASCVD risk reduction. Although statins represent the first-line inte...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruscica, Massimiliano, Sirtori, Cesare Riccardo, Ferri, Nicola, Corsini, Alberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8503511/
https://www.ncbi.nlm.nih.gov/pubmed/34650356
http://dx.doi.org/10.1093/eurheartj/suab090

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8503511/
https://www.ncbi.nlm.nih.gov/pubmed/34650356
http://dx.doi.org/10.1093/eurheartj/suab090

Ejemplares similares